Center for Molecular Medicine

07/12/2025

Geen stoute kindjes dit jaar!
Everybody behaved this year!

Geniet- enjoy!

Sinterklaas en zijn zwarte pieten

03/11/2025

🚨 We’re hiring a Postdoctoral Fellow in Leukemia Research!
Join Professor Zeger Debyser’s group at KU Leuven, part of the ADVANTAGE Division, to work on innovative leukemia therapies within the European ArTCell project.
You will develop and evaluate artificial CAR-T cells in cell and animal models at MolMed, which offers state-of-the-art facilities for molecular medicine in an interdisciplinary and translational environment.
📘 Profile:
PhD in biomedical or related sciences, experience in oncology and animal models, and a strong research record.
👉 Apply here: https://lnkd.in/e95iq35t
🔬

03/11/2025

🧬PhD Opportunity – HIV Cure (Block & Lock Strategy)

KU Leuven is hiring a PhD candidate to join Prof. Zeger Debyser’s lab at the Department of Pharmaceutical and Pharmacological Sciences. The project focuses on developing a “block and lock” cure strategy for HIV infection, aiming to achieve a functional cure by silencing the virus permanently.

📍 Location: Leuven, Belgium
🧠 Profile: Master’s in biomedical, pharmaceutical, biochemical sciences or related sciences
📅 Deadline: 24 Dec 2025

👉 Apply here: https://lnkd.in/gXhFsiB7

13/09/2025

Congratulations to our MolMed alumnus Mattijs Bulcaen.

Biochemicus Mattijs Bulcaen van KU Leuven heeft de Eos Pipet 2025 én de Publieksprijs gewonnen! Deze prijs bekroont de meest beloftevolle jonge wetenschapper van Vlaanderen. Mattijs slaagde erin DNA-fouten te corrigeren in cellen van mucoviscidosepatiënten. Hij zoekt nu een manier om de therapie veilig in de longen van patiënten te brengen en hen te verlossen van hun aandoening.

Lees meer over het onderzoek van Mattijs

👉 https://www.eoswetenschap.eu/gezondheid/mattijs-bulcaen-ku-leuven-wint-de-eos-pipet-2025-en-de-publieksprijs

____

KU Leuven biochemist Mattijs Bulcaen has won the Eos Pipet 2025 and the Audience Award! This award recognizes the most promising young scientist in Flanders. Mattijs succeeded in correcting DNA errors in cells from cystic fibrosis patients. He is now searching for a way to safely deliver the therapy to patients' lungs and cure them of their condition.

Read more about the research of Mattijs

👉 https://www.eoswetenschap.eu/gezondheid/mattijs-bulcaen-ku-leuven-wint-de-eos-pipet-2025-en-de-publieksprijs

09/06/2025

And also Thatcher is doing well in the Dana Farber

08/06/2025

We found him! In his lab in the famous Broad Institute: Mattijs Bulcaen. Alive and kicking!

22/05/2025

https://www.robtv.be/nieuws/onderzoekers-ku-leuven-ontwikkelen-nieuwe-methode-om-hiv-virussen-onschadelijk-te-maken-belangrijke-doorbraak-in-volledige-genezing-200801

De KU Leuven heeft een nieuwe methode ontwikkeld om HIV-virussen definitief onschadelijk te maken. Met de huidige HIV-medicatie worden op dit moment al heel

08/05/2025

Dinner with prof. Zhan Peng from Shandong University in China to celebrate our excellent collaboration.

25/04/2025

MolMed team Zeger on the move!
A Vespa adventure — great vibes, and even better company. Teambuilding at its finest 🏍️

13/02/2025

📢 PhD Defence Success – Anne Bruggemans 📢

Congratulations to Dr. Dr. Anne Bruggemans on successfully defending her PhD on February 11, 2025! 🎉👏 Her work, “HIV Latency: Through the Lens of LEDGF/p75, LEDGINs, and HIV-2,” has provided valuable insights into the molecular mechanisms of HIV persistence.

The MolMed Lab is incredibly proud of Anne’s dedication and contributions to the field. Wishing her all the best in her next chapter as an infectious disease specialist!

13/02/2025

Our multi-disciplinary STAT1 gain-of-function project is expanding and we are looking for a new and motivated colleague to join our team 🤩
If you know someone seeking for a PhD position who would be a great fit, please connect us.
Feel free to share this opportunity with your network. Thank you for spreading the word!

https://www.linkedin.com/jobs/view/4149668321

https://www.kuleuven.be/personeel/jobsite/jobs/60428149?lang=en

Posted 1:54:09 PM. The Allergy And Clinical Immunology Research Group And The Laboratory Of Molecular Virology And…See this and similar jobs on LinkedIn.

17/01/2025

🧬👏
Yesterday, Saskia Lesire successfully defended her PhD titled ‘The LINE-1 Retrotransposon: From Junk DNA to Emerging Human Pathogen.’

She delivered an outstanding presentation!
We are incredibly proud of Saskia and her hard work over the years. Congratulations, Dr. Lesire, on this well-deserved achievement!